Merck to buy Millipore for $7.2 billion
Boston Business Journal
March 01, 2010
German pharmaceutical titan Merck KGaA turns out to be the company gunning for an acquisition of Millipore Corp., and the Billerica life sciences company has agreed to its overtures to the tune of $7.2 billion in cash.
That makes each share of Millipore (NYSE:MIL) common stock worth $107 to Merck, which has said it will buy all outstanding shares. After the deal closes, Merck will keep Millipore based in Billerica, officials said, and plans to retain its senior management...read more
Boston Business Journal ©March 2010
|
